Lima Memorial Health System Logo
Approximate ER WAIT TIME
5

Health Library

Vitamin K deficiency bleeding of the newborn
Site Map

Vitamin K deficiency bleeding of the newborn

Hemorrhagic disease of the newborn (HDN)

Vitamin K deficiency bleeding (VKDB) of the newborn is a bleeding disorder in babies. It most often develops in the first days and weeks of life.

I Would Like to Learn About:

Causes

A lack of vitamin K may cause severe bleeding in newborn babies. Vitamin K plays an important role in blood clotting.

Babies often have a low level of vitamin K for a variety of reasons. Vitamin K does not move easily across the placenta from the mother to the baby. As a result, a newborn does not have much vitamin K stored up at birth. Also, the bacteria that help make vitamin K are not yet present in a newborn's gastrointestinal tract. Finally, there is not much vitamin K in mother's milk.

Your baby may develop this condition if:

  • A preventive vitamin K shot is not given at birth (if vitamin K is given by mouth instead of as a shot, it must be given more than once, and it does not appear to be as effective as the shot).
  • The mother takes certain anti-seizure or blood-thinning drugs.

The condition is grouped into three categories:

  • Immediate-onset VKDB is very rare. It occurs within the first 48 hours after birth and is usually a result of anti-seizure medicines or some other medicines, including a blood thinner called warfarin (Coumadin), taken by mothers during pregnancy.
  • Early-onset (formerly called “classic-onset”) disease is also rare. It occurs between 1 to 14 days after birth. It is usually seen in breastfed infants who did not receive a vitamin K shot.
  • Late-onset VKDB is seen in infants between 2 weeks and 6 months old. It is also more likely to happen in those who did not receive a vitamin K shot.

Anyone of any age with the following problems involving the gastrointestinal system is also at risk to develop this disorder:

Symptoms

Vitamin K deficiency causes bleeding. The most common areas of bleeding include:

  • At the site of circumcision
  • Belly button area
  • Gastrointestinal tract (resulting in blood in the baby's bowel movements)
  • Mucous membranes (such as the lining of the nose and mouth)
  • Places where there has been a needle stick
  • The brain

There may also be:

Exams and Tests

Blood clotting tests will be done.

The diagnosis can be confirmed if a vitamin K shot stops the bleeding and blood clotting time (PT or prothrombin time) quickly becomes normal (within 6 to 24 hours). (If the deficiency is not severe, the PT may not be abnormal.)

Treatment

Vitamin K is given if bleeding occurs. Babies with severe bleeding may need plasma or blood transfusions.

Outlook (Prognosis)

The outlook tends to be worse for babies with late-onset hemorrhagic disease than other forms. There is a higher rate of bleeding inside the skull (intracranial hemorrhage) associated with the late-onset condition.

Possible Complications

Complications may include:

  • Bleeding inside the skull (intracranial hemorrhage), with possible brain damage
  • Death

When to Contact a Medical Professional

Contact your health care provider if your baby has:

  • Any unexplained bleeding
  • Seizures
  • Abdominal behavior

Get emergency medical care right away if the symptoms are severe.

Prevention

The early onset form of the disease may be prevented by giving vitamin K shots to pregnant women who take anti-seizure medicines. To prevent the classic and late-onset forms, the American Academy of Pediatrics recommends giving every baby a shot of vitamin K immediately after birth. Because of this practice, vitamin K deficiency is now rare in the United States except for those babies who do not receive the vitamin K shot.

References

Greenbaum LA. Vitamin K deficiency. In: Kliegman RM, St. Geme JW, Blum NJ, Shah SS, Tasker RC, Wilson KM, eds. Nelson Textbook of Pediatrics. 21st ed. Philadelphia, PA: Elsevier; 2020:chap 66.

Hand I, Noble L, Abrams SA. Vitamin K and the newborn infant. Pediatrics. 2022;149(3):e2021056036. PMID: 35190810 pubmed.ncbi.nlm.nih.gov/35190810/.

Samji N, Chan A, Bhatt MD. Bleeding and clotting disorders in pediatrics. In: Hoffman R, Benz EJ, Silberstein LE, et al, eds. Hematology: Basic Principles and Practice. 8th ed. Philadelphia, PA: Elsevier; 2023:chap 148.

BACK TO TOP

Review Date: 12/31/2023  

Reviewed By: Mary J. Terrell, MD, IBCLC, Neonatologist, Cape Fear Valley Medical Center, Fayetteville, NC. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

ADAM Quality Logo

A.D.A.M., Inc. is accredited by URAC, for Health Content Provider (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics. This site complies with the HONcode standard for trustworthy health information: verify here.

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, timeliness, or correctness of any translations made by a third-party service of the information provided herein into any other language. © 1997- 2024 A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

adam.com

A.D.A.M. content is best viewed in IE9 or above, Firefox and Google Chrome browser.